Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Interim Management Statement

15 Jul 2014 07:00

RNS Number : 2705M
Charlemagne Capital Limited
15 July 2014
Β 

15 July 2014

Β 

Β 

Interim Management Statement for the Six Months Ended 30 June 2014

Β 

Charlemagne Capital Limited (the "Group") sets out below the key revenue items and assets under management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced on 16 September 2014.

Β 

Key highlights and Group AuM

Β 

Β§ As at 30 June 2014, Group AuM were US$2.8 billion, up by 3.6% since 1 January 2014;

Β 

Β§ Net management fees of US$12.4 million, up 3.3% on the previous six months;

Β 

Β· The Group remains well-capitalised with a strong and liquid balance sheet; and

Β 

Β· Positive net inflows over the period

Β 

Β 

The table below sets out the Group's AuM as at 30 June 2014 and the movements experienced in each product range in the period since 1 January 2014.

Β 

01-Jan-14

Net Subscriptions

Net Performance

30-Jun-14

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

560

124

22.1

37

5.9

721

28.8

OCCO

664

23

3.5

0

0.0

687

3.5

Institutional

1,373

(111)

(8.1)

16

1.2

1,278

(6.9)

Specialist

134

12

9.0

(3)

(2.1)

143

6.7

Total

2,731

48

1.8

50

1.8

2,829

3.6

Β 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

Β 

Unaudited revenue numbers for the six months ended 30 June 2014

Β 

Net management fees receivable were US$12.4 million compared with US$12.0 million for the previous six months and US$11.9 million for the comparable period of 2013, reflecting the small increase in average AuM and net margin arising over the period. OCCO management fees, which are subject to a minority interest, accounted for over 45% of total net management fee income during the period.

Β 

Crystallised performance fees were US$0.3 million compared with US$0.5 million for the comparative period in 2013. Accruing performance fees1 for 2014 which have not crystallised were US$0.5 million compared with US$5.9 million as at the same date in 2013.

Β 

_________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

Β 

Dividend

Β 

In the absence of unforeseen circumstances, the Group intends to declare an interim dividend in respect of the six months to 30 June 2014. Further details will be provided in the interim results announcement planned for 16 September 2014.

Β 

Summary

Β 

Emerging markets have returned a positive performance over the six month period with gains in the second quarter overcoming negative returns in the first, the low point being in February. The MSCI Emerging markets index was up by 6.6% for the quarter resulting in a 6.1% (in US$) gain over the full half year. This turnaround follows six months of heavy and almost continuous selling by mutual funds and suggests that sentiment may be turning. Investors are adjusting to the ending of super-easy monetary policy in the US, with emerging currencies recovering from weakness of the previous nine months, while political risk has reduced following the BJP' victory in India as well as elections in South Africa, Turkey and Indonesia.

Β 

Over the period, four of the nine Magna sub-funds were in the top half of their FactSet Morningstar peer group. The overall performance in the institutional funds business was lower than the broader market performance, because a number of the largest mandates are focused on Eastern Europe or Russia. These were the markets most affected by the crisis in Ukraine, which showed signs of abating towards the end of the half.

Β 

The positive net inflows into the Magna funds over the first half of the year are predominantly due to subscriptions into the Magna Emerging Markets Dividend Fund with net inflows also achieved into MENA and Frontier funds. The institutional business was impacted by rebalancing of existing mandates, together with outflows from sub advisory business. The OCCO Eastern European Fund had net inflows as capacity from earlier redemptions was filled.

Β 

Outlook

Β 

During the year to date, emerging markets have performed similarly to developed markets after a sustained period of underperformance. The industry has reported outflows from dedicated emerging markets funds over the period although this trend has started to reverse in the most recent quarter. While economic growth in some countries may be subdued, the outlook for many is improving. From a bottom up perspective, we see evidence of more realistic earnings expectations, which should help share prices in the asset class.

Β 

The Group has again seen net inflows in a challenging environment and has achieved modest growth in AuM. The current level of AuM remains below that required to ensure sustainable profits on a recurring management fee basis and the generation of performance fees during the remainder of the year will be a significant factor in determining full year profit levels.

Β 

Enquiries:

Β 

Charlemagne Capital

Β 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

Β 

Β 

N+1 Singer

Tel. 020 7496 3000

Jonny Franklin-Adams

Nick Donovan

Β 

Β 

Β 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSDMGMNDDVGDZM
Date   Source Headline
15th Sep 20082:33 pmRNSDirector/PDMR Shareholding
15th Sep 200810:25 amRNSHolding(s) in Company
11th Sep 20087:00 amRNSTransaction in Own Shares
8th Sep 20087:00 amRNSTransaction in Own Shares
5th Sep 20087:00 amRNSTransaction in Own Shares
4th Sep 20081:49 pmRNSViewing Interim Financial Sta
3rd Sep 20087:01 amRNSDividend Declaration
3rd Sep 20087:00 amRNSInterim Results
14th Aug 20087:00 amRNSNotice of Results
13th Aug 20087:00 amRNSDividend Election Procedure
11th Jul 20087:00 amRNSHalf Year Trading Statement
18th Jun 20087:00 amRNSAnnual Report and Interim Res
27th May 20087:00 amRNSLaunch of New Fund
7th May 200812:32 pmRNSResult of AGM
7th May 20089:13 amRNSAGM Statement
15th Apr 20089:20 amRNSDirector/PDMR Shareholding
15th Apr 20087:00 amRNSDirector/PDMR Shareholding
11th Apr 200811:19 amRNSDirector/PDMR Shareholding
9th Apr 20087:00 amRNSStatement re Q1 AuM Update
28th Mar 200810:03 amRNSDirector/PDMR Shareholding
19th Mar 20081:38 pmRNSDirector/PDMR Shareholding
6th Mar 20083:39 pmRNSHolding(s) in Company
4th Mar 20085:38 pmRNSTransaction in Own Shares
27th Feb 20084:38 pmRNSDirectorate Change
27th Feb 20084:34 pmRNSHolding(s) in Company
27th Feb 20087:01 amRNSDividend Declaration
27th Feb 20087:01 amRNSFinal Results
15th Feb 20085:22 pmRNSHolding(s) in Company
7th Feb 20085:02 pmRNSHolding(s) in Company
7th Feb 200812:25 pmRNSHolding(s) in Company
31st Jan 20085:37 pmRNSHolding(s) in Company
25th Jan 20087:00 amRNSNotice of Final Results
15th Jan 20083:08 pmRNSHolding(s) in Company
10th Jan 20087:00 amRNSTrading Statement
9th Jan 20087:00 amBUSHolding(s) in Company
2nd Jan 20084:42 pmRNSHolding(s) in Company
10th Dec 20079:23 amRNSDirector/PDMR Shareholding
10th Dec 20079:19 amRNSHolding(s) in Company
30th Nov 20077:35 amRNSTransaction in Own Shares
21st Nov 20075:48 pmRNSTransaction in Own Shares
19th Nov 20075:37 pmRNSTransaction in Own Shares
16th Nov 20075:36 pmRNSTransaction in Own Shares
14th Nov 20077:01 amRNSE. European OCCO Fund Closes
6th Nov 20075:24 pmRNSTransaction in Own Shares
17th Oct 20077:00 amRNSTransaction in Own Shares
15th Oct 20077:01 amRNSTransaction in Own Shares
4th Oct 20077:01 amRNSAssets under Manage
4th Oct 20077:01 amRNSTransaction in Own Shares
19th Sep 20075:58 pmRNSTransaction in Own Shares
17th Sep 20075:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.